1. Home
  2. APOG vs NXPLW Comparison

APOG vs NXPLW Comparison

Compare APOG & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APOG
  • NXPLW
  • Stock Information
  • Founded
  • APOG 1949
  • NXPLW N/A
  • Country
  • APOG United States
  • NXPLW United States
  • Employees
  • APOG N/A
  • NXPLW N/A
  • Industry
  • APOG Auto Parts:O.E.M.
  • NXPLW Telecommunications Equipment
  • Sector
  • APOG Consumer Discretionary
  • NXPLW Telecommunications
  • Exchange
  • APOG Nasdaq
  • NXPLW Nasdaq
  • Market Cap
  • APOG N/A
  • NXPLW N/A
  • IPO Year
  • APOG N/A
  • NXPLW N/A
  • Fundamental
  • Price
  • APOG $48.16
  • NXPLW $0.21
  • Analyst Decision
  • APOG Hold
  • NXPLW
  • Analyst Count
  • APOG 1
  • NXPLW 0
  • Target Price
  • APOG $62.00
  • NXPLW N/A
  • AVG Volume (30 Days)
  • APOG 241.4K
  • NXPLW 6.4K
  • Earning Date
  • APOG 04-17-2025
  • NXPLW 03-31-2025
  • Dividend Yield
  • APOG 2.16%
  • NXPLW N/A
  • EPS Growth
  • APOG N/A
  • NXPLW N/A
  • EPS
  • APOG 4.47
  • NXPLW N/A
  • Revenue
  • APOG $1,377,140,000.00
  • NXPLW $66,482,000.00
  • Revenue This Year
  • APOG N/A
  • NXPLW N/A
  • Revenue Next Year
  • APOG $1.53
  • NXPLW N/A
  • P/E Ratio
  • APOG $10.78
  • NXPLW N/A
  • Revenue Growth
  • APOG N/A
  • NXPLW 179.89
  • 52 Week Low
  • APOG $47.63
  • NXPLW $0.25
  • 52 Week High
  • APOG $87.93
  • NXPLW $0.26
  • Technical
  • Relative Strength Index (RSI)
  • APOG 26.14
  • NXPLW N/A
  • Support Level
  • APOG $48.86
  • NXPLW N/A
  • Resistance Level
  • APOG $50.79
  • NXPLW N/A
  • Average True Range (ATR)
  • APOG 1.26
  • NXPLW 0.00
  • MACD
  • APOG 0.51
  • NXPLW 0.00
  • Stochastic Oscillator
  • APOG 11.86
  • NXPLW 0.00

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: